These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 11284945)
1. In vitro activity of moxifloxacin against Stenotrophomonas maltophilia blood isolates from patients with hematologic malignancies. Venditti M; Monaco M; Micozzi A; Tarasi A; Friedrich A; Martino P Clin Microbiol Infect; 2001 Jan; 7(1):37-9. PubMed ID: 11284945 [No Abstract] [Full Text] [Related]
2. Susceptibility to antimicrobial agents of Stenotrophomonas maltophilia isolated from patients with cancer and bacteremia. Krcmery V; Trupl J; Svetlansky I Clin Infect Dis; 2001 Jun; 32(11):1656. PubMed ID: 11340542 [No Abstract] [Full Text] [Related]
3. Post-antibiotic effect (PAE) of moxifloxacin in multidrug-resistant Stenotrophomonas maltophilia. Korakianitis I; Mirtsou V; Gougoudi E; Raftogiannis M; Giamarellos-Bourboulis EJ Int J Antimicrob Agents; 2010 Oct; 36(4):387-9. PubMed ID: 20674284 [No Abstract] [Full Text] [Related]
4. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan. Sheng WH; Wang JT; Chen YC; Chang SC; Luh KT J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808 [TBL] [Abstract][Full Text] [Related]
5. Activity of levofloxacin and ciprofloxacin on biofilms and planktonic cells of Stenotrophomonas maltophilia isolates from patients with device-associated infections. Passerini de Rossi B; García C; Calenda M; Vay C; Franco M Int J Antimicrob Agents; 2009 Sep; 34(3):260-4. PubMed ID: 19362452 [TBL] [Abstract][Full Text] [Related]
6. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Micozzi A; Venditti M; Monaco M; Friedrich A; Taglietti F; Santilli S; Martino P Clin Infect Dis; 2000 Sep; 31(3):705-11. PubMed ID: 11017819 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: can moxifloxacin activity be predicted by levofloxacin MIC results? Galles AC; Jones RN; Sader HS J Chemother; 2008 Feb; 20(1):38-42. PubMed ID: 18343741 [TBL] [Abstract][Full Text] [Related]
8. In vitro killing effect of moxifloxacin on clinical isolates of Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole. Giamarellos-Bourboulis EJ; Karnesis L; Galani I; Giamarellou H Antimicrob Agents Chemother; 2002 Dec; 46(12):3997-9. PubMed ID: 12435710 [TBL] [Abstract][Full Text] [Related]
9. [Molecular epidemiology of Stenotrophomonas maltophilia strains isolated from paediatric patients]. Köseoğlu O; Sener B; Gür D Mikrobiyol Bul; 2004; 38(1-2):9-19. PubMed ID: 15293897 [TBL] [Abstract][Full Text] [Related]
10. Stenotrophomonas maltophilia bacteremia in pediatric patients-- a 10-year analysis. Wu PS; Lu CY; Chang LY; Hsueh PR; Lee PI; Chen JM; Lee CY; Chan PC; Chang PY; Yang TT; Huang LM J Microbiol Immunol Infect; 2006 Apr; 39(2):144-9. PubMed ID: 16604247 [TBL] [Abstract][Full Text] [Related]
11. [Surveillance on antibiotic resistance of Stenotrophomonas maltophilia in Chengdu and Chongqing area]. Tao CM; Li XC; Lü XJ; Li P; Yu RJ; Gao YY; Chen HL Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):91-3. PubMed ID: 14981826 [TBL] [Abstract][Full Text] [Related]
13. In vitro activities of moxifloxacin and other fluoroquinolones against Mycoplasma pneumoniae. Hamamoto K; Shimizu T; Fujimoto N; Zhang Y; Arai S Antimicrob Agents Chemother; 2001 Jun; 45(6):1908-10. PubMed ID: 11353651 [TBL] [Abstract][Full Text] [Related]
14. Emergence of fluoroquinolone-resistant Stenotrophomonas maltophilia in blood isolates causing bacteremia: molecular epidemiology and microbiologic characteristics. Cha MK; Kang CI; Kim SH; Cho SY; Ha YE; Chung DR; Peck KR; Song JH Diagn Microbiol Infect Dis; 2016 Jun; 85(2):210-2. PubMed ID: 27117514 [TBL] [Abstract][Full Text] [Related]
15. Pseudooutbreak of Stenotrophomonas maltophilia bacteremia in a general ward. Park YS; Kim SY; Park SY; Kang JH; Lee HS; Seo YH; Cho YK Am J Infect Control; 2008 Feb; 36(1):29-32. PubMed ID: 18241733 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia. Chen CY; Tsay W; Tang JL; Tien HF; Chen YC; Chang SC; Hsueh PR Epidemiol Infect; 2010 Jul; 138(7):1044-51. PubMed ID: 19941686 [TBL] [Abstract][Full Text] [Related]
17. The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients. Rolston KV; Yadegarynia D; Kontoyiannis DP; Raad II; Ho DH Int J Infect Dis; 2006 May; 10(3):223-30. PubMed ID: 16439177 [TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activity of quinolones against Stenotrophomonas maltophilia. Valdezate S; Vindel A; Baquero F; Cantón R Eur J Clin Microbiol Infect Dis; 1999 Dec; 18(12):908-11. PubMed ID: 10691206 [TBL] [Abstract][Full Text] [Related]
19. [Nosocomial Stenotrophomonas maltophilia infections in a university hospital]. Caylan R; Yilmaz G; Sucu N; Bayraktar O; Aydin K; Kaklikkaya N; Aydin F; Köksal I Mikrobiyol Bul; 2005 Jan; 39(1):25-33. PubMed ID: 15900834 [TBL] [Abstract][Full Text] [Related]
20. Stenotrophomonas maltophilia: the significance and role as a nosocomial pathogen. Senol E J Hosp Infect; 2004 May; 57(1):1-7. PubMed ID: 15142709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]